CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

The Personal Exoskeleton in use. [Image courtesy of Wandercraft] Wandercraft announced that it kicked off a landmark clinical ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist ...

Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...

Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.